Loading...

Purified anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_Pure_021606
C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_Pure_021606
    C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_033017
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD3ε (clone 145-2C11) and 10 µg/mL of Alexa Fluor® 488 anti-mouse/human CD45R/B220 (clone RA3-6B2) (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 Goat anti-hamster (Armenian) IgG (clone Poly4055) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_2_102518
    Fresh, frozen mouse spleen was stained with purified CD3ε clone 145-2C11 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Cat # Size Price Quantity Check Availability Save
100301 50 µg 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100302 500 µg 58€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Activ, Block, WB, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  2. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  3. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  4. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  5. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  6. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  7. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  8. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  9. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  10. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  11. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  12. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  13. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  14. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  15. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  16. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  17. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  18. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  19. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  20. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  21. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  22. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  23. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  24. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  25. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  26. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  27. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  28. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  29. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  30. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  31. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  32. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  33. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  34. Goel S, et al. 2017. Nature. 548:471. PubMed
  35. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  36. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  37. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  38. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  39. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  40. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  41. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  42. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  43. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  44. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  45. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  46. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  47. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  48. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  49. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  50. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  51. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  52. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  53. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  54. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  55. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  56. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  57. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  58. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  59. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  60. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  61. Du J, et al. 2018. AMB Express. 8:158. PubMed
  62. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  63. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  64. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  65. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  66. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  67. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  68. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  69. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  70. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  71. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  72. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  73. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  74. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  75. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  76. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  77. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  78. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  79. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  80. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  81. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  82. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  83. Majer O, et al. 2019. Nature. 575:366. PubMed
  84. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  85. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  86. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  87. Guo Y, et al. 2008. Blood. 112:480. PubMed
  88. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  89. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  90. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  91. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  92. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  93. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  94. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  95. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  96. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  97. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  98. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  99. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  100. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  101. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  102. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  103. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  104. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  105. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  106. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  107. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  108. Lu SX, et al. 2021. Cell. . PubMed
  109. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  110. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  111. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  112. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  113. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  114. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  115. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  116. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  117. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  118. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  119. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  120. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  121. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  122. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  123. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  124. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  125. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  126. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  127. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  128. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  129. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  130. Willimsky G, et al. 2021. Elife. 10:. PubMed
  131. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  132. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  133. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  134. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  135. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  136. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  137. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  138. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  139. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  140. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  141. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  142. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  143. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  144. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  145. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  146. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  147. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  148. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  149. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  150. Rigo MM, et al. 2020. FEBS J. :. PubMed
  151. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  152. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  153. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  154. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  155. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  156. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  157. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  158. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  159. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  160. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  161. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  162. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  163. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  164. Lee J, et al. 2020. Cells. 9:. PubMed
  165. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  166. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  167. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  168. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  169. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  170. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  171. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  172. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  173. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  174. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  175. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  176. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  177. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  178. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  179. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  180. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  181. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  182. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  183. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  184. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  185. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  186. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  187. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  188. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  189. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  190. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  191. Schick J, et al. 2023. Elife. 12: . PubMed
  192. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  193. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  194. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
RRID
AB_312666 (BioLegend Cat. No. 100301)
AB_312667 (BioLegend Cat. No. 100302)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10/17/2017

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account